Summary
Aware's fourth quarter of fiscal 2017 was a sharp reversal. Revenue was $3.06 million. The company swung to an operating loss of $0.48 million from operating income of $0.64 million in the prior-year quarter, a decline of $1.12 million or 174.6%. Net loss was $0.58 million, compared with net income of $0.46 million in the prior-year quarter, down $1.04 million or 226.1%. Diluted EPS was a loss of $0.03, down $0.05 or 250.0% from $0.02. Operating margin was -15.6% for the quarter. The quarter's weakness capped a difficult year.
For fiscal 2017, revenue was $15.46 million. Operating income fell to $1.81 million, down $4.10 million or 69.4% from $5.91 million in fiscal 2016. Net income was $1.28 million, down $2.82 million or 68.8% from $4.10 million. Diluted EPS was $0.06, down $0.12 or 66.7% from $0.18. Full-year operating margin was 11.7%. The annual decline was broad based.
Cash generation held up better in the quarter. Operating cash flow was $3.06 million in the fourth quarter, up $1.94 million or 173.0% from $1.12 million in the prior-year quarter. For the full year, operating cash flow was $3.67 million, down $0.14 million or 3.8% from $3.81 million. Capital expenditures were $21,000 in the quarter, up 320.0% from $5,000 in the prior-year quarter. Full-year capital expenditures were $82,000, down 5.7% from $87,000. Deferred revenue stood at $2.93 million. These are operating cash flow figures, not free cash flow.
Management's annual discussion points to several operational causes. Lower revenue and operating income in 2017 came primarily from lower biometrics software license sales to the United States Marine Corps and the United States Navy. Lower imaging product license sales also hurt. A large 2015 imaging license sale was recognized over a twelve-month period that ran from October 2015 to October 2016, and no remaining license revenue from that agreement was left in 2017. Software maintenance revenue, services revenue, and DSL royalties all declined. Hardware sales were zero. Operating expenses rose. Partial offsets came from higher patent related income, lower cost of software licenses, and lower cost of hardware.
The company also has a patent arrangement with an unaffiliated third party. It assigned certain patents in 2010 in return for royalties on patent monetization efforts. It recorded income from that arrangement in 2017 and 2016, but it cannot predict how much more income it might receive. The Certisign service rollout continues but has not produced meaningful revenue to date. Commercial markets have been slow to develop.
The outlook carries real risks. Services backlog was minimal as of December 31, 2017, and management expects services revenue in fiscal 2018 to remain below the levels achieved in 2014 and 2015. There was no hardware product backlog as of December 31, 2017, and future Navy hardware orders may be minimal. DSL royalties are expected to keep declining. Management cannot predict whether the USMC or Navy will purchase software again. The Internal Revenue Service commenced an examination of the company's 2015 tax return, and the company said it had no indication of the outcome. The adoption of the new revenue standard will also reduce reported revenue for fiscal 2017 and 2016 comparatives.
The fourth quarter shows a company with operating cash flow improvement but weak earnings power. Operating cash flow improved in the quarter, yet the full-year trend was down. Revenue concentration in government biometrics programs remains a central issue. Management's fiscal 2018 commentary is cautious on services and hardware. The patent and royalty streams are uncertain, and the new revenue standard adds another layer of comparability noise. The company's revenue base remains concentrated, and management's commentary offers limited visibility on future revenue.
Forecast
Reported figures
GAAP, from SEC filings| Metric | Q4 FY2017 | Q3 FY2017 | QoQ | Q4 FY2016 | YoY |
|---|---|---|---|---|---|
| Revenue | $335.0K | $343.0K | -2.3% | $688.0K | -51.3% |
| Gross profit | $233.0K | $165.0K | +41.2% | $971.0K | -76.0% |
| Gross margin | 69.5% | 48.1% | +21.4 pp | 141.1% | -71.6 pp |
| Research & development | $1.9M | $2.2M | -12.4% | $1.7M | +8.7% |
| Sales & marketing | $1.0M | $1.1M | -5.0% | $1.0M | -3.9% |
| General & administrative | $935.0K | $849.0K | +10.1% | $834.0K | +12.1% |
| Total operating expenses | $3.9M | $4.3M | -7.9% | $3.9M | +1.7% |
| Operating income (loss) | -$478.0K | $1.7M | -128.7% | $641.0K | -174.6% |
| Operating margin | -142.7% | 485.4% | -628.1 pp | 93.2% | -235.9 pp |
| Net income (loss) | -$581.0K | $1.2M | -147.3% | $460.0K | -226.3% |
| Net margin | -173.4% | 358.3% | -531.7 pp | 66.9% | -240.3 pp |
| Diluted EPS | -$0.03 | $0.06 | -$0.09 | $0.02 | -$0.05 |
Risks
A significant portion of revenue is derived directly or indirectly from federal, international, state, and local governments. MD&A attributes lower 2017 results to lower biometrics software license sales to the USMC and Navy, and notes uncertainty about whether they will purchase again.
Individual orders can represent a meaningful percentage of revenue and net income in any single quarter, and timing is difficult to predict. In FY2017 Q4 operating income swung to a loss of $0.48 million from income of $0.64 million in FY2016 Q4, and net income swung to a loss of $0.58 million from $0.46 million.
Growth strategy depends on expansion into commercial biometrics markets, but commercial acceptance remains limited. MD&A states the Certisign service rollout continues but has not resulted in meaningful revenue to date, and commercial markets generally continued to be slow to develop in 2017.
Loss of a key customer or one of its key customers could materially harm results. MD&A cites lower software license sales to the USMC and Navy, and notes there was no license sale as large as the 2016 systems integrator/U.S. government end user sale in 2017.
Adoption of the new revenue standard effective January 1, 2018 using the full retrospective method is expected to decrease revenue and net income for fiscal 2017 and 2016 and affect stockholders' equity. This may reduce comparability of reported results.
A significant portion of revenue comes through third party systems integrators and OEM partners. Failure to manage these relationships, or a partner's failure to win government awards, could impair sales.
Intense competition from larger diversified technology providers and component providers, as well as low cost foreign competitors, may pressure prices and market share. MD&A notes competitive pressures on selling prices.
The IRS commenced an examination of the company's 2015 tax return in 2017. The Tax Cuts and Jobs Act reduced the corporate rate and required revaluation of deferred tax assets, which affected income tax expense.
Services backlog was minimal as of December 31, 2017. MD&A states services revenue in 2018 is unlikely to return to the levels achieved in 2014 and 2015.
Patent related income contributed to 2017 operating results, but the company is unable to predict how much more income it might receive from the patent arrangement because patent monetization efforts may not be successful.
Biometrics solutions face public concerns regarding privacy and potential privacy legislation. Such concerns or new laws could limit demand for biometrics products.
Hardware revenue ceased in 2017, and there was no hardware backlog as of December 31, 2017. Future hardware orders may be minimal and the company's strategy does not include selling biometrics hardware.
Royalty revenue decreased in 2017 and is expected to continue to decline. One royalty customer reported no royalties in 2017 and the other is likely to satisfy its royalty obligation in 2018.
Summary, forecast, risks and KPIs are extracted from AWARE INC /MA/'s SEC filings for Q4 FY2017 (10-Q / 10-K and the 8-K earnings release); GAAP figures in the summary are checked against the reported XBRL data. They can contain errors; the filings are authoritative. Processed Nov 9, 2026.